Palvella Therapeutics, Inc. (PVLA) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$21.41M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income -$14.86M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -$10.18M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -$9.25M; Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2021-12-31 to 2023-12-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$21.41M | (m) | (m) | (m) | (m) | -$12.85M* | (m) | $12.47M | (m) | $0.00 |
|---|
| 2026-03-31 | Reported | (m) | -$14.86M | (m) | (m) | (m) | (m) | -$10.86M | (m) | $9.33M | (m) | $0.00 |
|---|
| 2025-09-30 | Reported | (m) | -$10.18M | (m) | (m) | (m) | (m) | -$7.88M* | (m) | $6.53M | (m) | $0.00 |
|---|
| 2025-06-30 | Reported | (m) | -$9.25M | (m) | (m) | (m) | (m) | -$5.43M* | (m) | $5.12M | (m) | $0.00 |
|---|
| 2025-03-31 | Reported | (m) | -$7.87M | (m) | (m) | (m) | (m) | -$6.77M | (m) | $4.07M | (m) | $0.00 |
|---|
| 2024-09-30 | Reported | (m) | -$5.06M | (m) | (m) | (m) | $0.00* | -$2.74M* | (m) | $3.18M | (m) | $0.00 |
|---|
| 2024-06-30 | Reported | (m) | -$2.91M | (m) | (m) | (m) | $0.00* | -$1.60M* | (m) | $1.44M | (m) | $0.00 |
|---|
| 2024-03-31 | Reported | (m) | -$1.76M | (m) | (m) | (m) | $0.00 | -$1.10M | (m) | $984.00K | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | $13.19M | (m) | (m) | (m) | 1260.80% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$11.07M* | -$11.81M | $739.00K* | (m) | (m) | $69.00K* | -$9.72M* | (m) | $9.60M | (m) | (m) |
|---|
| 2023-06-30 | Reported | $2.82M* | $2.06M | $758.00K* | (m) | (m) | $67.00K* | -$13.43M* | (m) | $14.33M | (m) | (m) |
|---|
| 2023-03-31 | Reported | -$14.91M | (m) | (m) | (m) | -741.59% | $48.00K | -$11.00M | (m) | $13.42M | (m) | (m) |
|---|
| 2022-12-31 | Reported | -$10.94M | (m) | (m) | (m) | -191.70% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$11.40M* | -$12.17M | $767.00K* | (m) | (m) | $34.00K* | -$8.78M* | (m) | $13.59M | (m) | (m) |
|---|
| 2022-06-30 | Reported | -$11.75M* | -$12.33M | $583.00K* | (m) | (m) | $629.00K* | -$15.58M* | (m) | $11.95M | (m) | (m) |
|---|
| 2022-03-31 | Reported | -$6.61M | (m) | (m) | (m) | -59.14% | $389.00K | -$22.64M | (m) | $14.07M | (m) | (m) |
|---|
| 2021-12-31 | Reported | -$10.39M | (m) | (m) | (m) | -134.05% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | (m) | -$19.01M | (m) | (m) | (m) | $350.00K* | -$14.48M* | (m) | $18.94M | (m) | (m) |
|---|
| 2021-06-30 | Reported | (m) | -$16.76M | (m) | (m) | (m) | $229.00K* | $29.91M* | (m) | $15.80M | (m) | (m) |
|---|
| 2021-03-31 | Reported | (m) | -$5.06M | (m) | (m) | (m) | $28.00K | -$12.14M | (m) | $16.56M | (m) | (m) |
|---|
| 2020-09-30 | Reported | (m) | -$13.00M | (m) | (m) | (m) | -$840.00K* | -$7.57M* | (m) | $11.82M | (m) | (m) |
|---|
| 2020-06-30 | Reported | (m) | -$4.66M | (m) | (m) | (m) | $1.06M* | -$9.78M* | (m) | $11.33M | (m) | (m) |
|---|
| 2020-03-31 | Reported | (m) | -$3.86M | (m) | (m) | (m) | $1.93M | -$15.13M | (m) | $12.76M | (m) | (m) |
|---|
| 2019-09-30 | Reported | (m) | -$2.91M | (m) | $14.50M | (m) | $232.00K* | -$12.65M* | (m) | $13.21M | (m) | $0.00 |
|---|
| 2019-06-30 | Reported | (m) | -$12.23M | (m) | $4.93M | (m) | $933.00K* | -$10.73M* | (m) | $13.37M | (m) | $0.00 |
|---|
| 2019-03-31 | Reported | (m) | -$10.68M | (m) | $7.53M | (m) | $121.00K | -$15.11M | (m) | $14.30M | (m) | $0.00 |
|---|
| 2018-09-30 | Reported | (m) | -$7.80M | (m) | $7.87M | (m) | $325.00K* | -$14.36M* | (m) | $11.40M | (m) | $0.00 |
|---|
| 2018-06-30 | Reported | (m) | -$2.24M | (m) | $11.22M | (m) | $394.00K* | -$8.99M* | (m) | $9.15M | (m) | -$148.00K |
|---|
| 2018-03-31 | Reported | (m) | -$8.14M | (m) | $3.44M | (m) | $414.00K | $31.34M | (m) | $7.94M | (m) | $0.00 |
|---|
| 2017-09-30 | Reported | (m) | -$5.18M | (m) | (m) | (m) | $289.00K* | (m) | (m) | $6.26M | (m) | $146.00K |
|---|
| 2017-06-30 | Reported | (m) | -$7.89M | (m) | (m) | (m) | $663.00K* | (m) | (m) | $5.40M | (m) | $814.00K |
|---|
| 2017-03-31 | Reported | (m) | -$8.01M | (m) | (m) | (m) | $179.00K | (m) | (m) | $5.36M | (m) | $0.00 |
|---|
| 2016-09-30 | Reported | (m) | -$6.18M | (m) | (m) | (m) | $198.10K* | (m) | (m) | $4.62M | (m) | (m) |
|---|
| 2016-06-30 | Reported | (m) | -$5.80M | (m) | (m) | (m) | $56.69K* | (m) | (m) | $4.50M | (m) | $0.00 |
|---|
| 2016-03-31 | Reported | (m) | -$4.38M | (m) | (m) | (m) | $67.92K | (m) | (m) | $3.66M | (m) | $0.00 |
|---|
| 2015-09-30 | Reported | (m) | -$3.88M | (m) | (m) | (m) | $194.98K* | (m) | (m) | $2.05M | (m) | $40.44K |
|---|
| 2015-06-30 | Reported | (m) | -$3.53M | (m) | (m) | (m) | $33.64K* | (m) | (m) | $1.73M | (m) | $0.00 |
|---|
| 2015-03-31 | Reported | (m) | -$3.70M | (m) | (m) | (m) | $40.65K | (m) | (m) | $1.52M | (m) | $0.00 |
|---|
| 2014-09-30 | Reported | (m) | -$1.84M | (m) | (m) | (m) | $0.00 | -$13.92K | (m) | $926.60K | (m) | $0.00* |
|---|
| 2014-06-30 | Reported | (m) | -$2.77M | (m) | (m) | (m) | (m) | (m) | (m) | $1.12M | (m) | (m) |
|---|
| 2014-03-31 | Reported | (m) | -$671.22K | (m) | (m) | (m) | $1.77K | -$294.00 | (m) | $1.22M | (m) | -$18.00 |
|---|
| 2013-12-31 | Reported | (m) | -$2.20K | (m) | (m) | (m) | $0.00 | -$948.00 | (m) | (m) | (m) | (m) |
|---|
| 2013-09-30 | Reported | (m) | -$5.76K | (m) | (m) | (m) | $0.00 | -$4.51K | (m) | (m) | (m) | $0.00 |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | (m) | -$38.60M | (m) | (m) | (m) | (m) | -$25.01M | (m) | $22.84M | (m) | $0.00 |
|---|
| 2024-12-31 | Reported | (m) | -$14.10M | (m) | (m) | (m) | (m) | -$10.84M | (m) | $8.15M | (m) | $0.00 |
|---|
| 2023-12-31 | Reported | -$9.97M | (m) | (m) | (m) | -25.74% | $171.00K | -$13.70M | (m) | $8.79M | (m) | $0.00 |
|---|
| 2022-12-31 | Reported | -$40.7M | (m) | (m) | (m) | -159.82% | $1.04M | -$59.93M | (m) | $52.98M | (m) | $0.00 |
|---|
| 2021-12-31 | Reported | -$49.37M | (m) | (m) | (m) | -176.71% | $949.00K | -$7.66M | (m) | $66.66M | (m) | $0.00 |
|---|
| 2020-12-31 | Reported | (m) | -$33.92M | (m) | (m) | (m) | $2.73M | -$45.90M | (m) | $46.53M | (m) | $164.00K |
|---|
| 2019-12-31 | Reported | (m) | -$27.16M | (m) | $43.65M | (m) | $2.46M | -$52.47M | (m) | $55.00M | (m) | $0.00 |
|---|
| 2018-12-31 | Reported | (m) | -$30.83M | (m) | $27.25M | (m) | $1.70M | -$1.07M | (m) | $41.49M | (m) | -$312.00K |
|---|
| 2017-12-31 | Reported | (m) | -$14.59M | (m) | (m) | (m) | $1.95M | $49.75M | (m) | $22.29M | (m) | $1.10M |
|---|
| 2016-12-31 | Reported | (m) | -$22.76M | (m) | (m) | (m) | $560.00K | (m) | (m) | $19.70M | (m) | $162.00K |
|---|
| 2015-12-31 | Reported | (m) | -$13.68M | (m) | (m) | (m) | $620.75K | (m) | (m) | $8.24M | (m) | $203.87K |
|---|
| 2014-12-31 | Reported | (m) | -$7.20M | (m) | (m) | (m) | $267.41K | (m) | (m) | $5.60M | (m) | -$18.00 |
|---|
| 2014-06-30 | Reported | (m) | -$15.71K | (m) | (m) | (m) | $0.00 | -$15.06K | (m) | (m) | (m) | $0.00 |
|---|
| 2013-12-31 | Reported | (m) | $553.83K | (m) | (m) | (m) | $49.47K | (m) | (m) | $9.41M | (m) | (m) |
|---|